Home > What's New > Current > Bionano Genomics 2022 Symposium @ Jan 10 -13, 2022
Bionano Genomics 2022 Symposium @ Jan 10 -13, 2022
2022-01-06 12:11:43 Source：Gene Company Limited
![virtual_event_header_banner_image_0943dfad0bd7107ade0926dbbb43eecfc96d0123_1993[1].jpg](/uploads/UE/images/20220106/1641441671334486.jpg "1641441671334486.jpg")
At the Bionano Genomics 2022 Symposium, you will hear from 25 distinguished scientists around the world who will showcase their findings and answers using OGM. Each day will feature customer presentations, a live panel with Q&A, as well as poster presentations by topic area. Below is an overview of the presentation topics for each day of the event.
Date: January 10 - 14 Time: Every 0:00 (HK time)
All presentations will be recorded and available on demand after the symposium concludes.
Schedule:
Monday, January 10: Constitutional Cytogenomics
Seven speakers from around the world will present their experiences using the Saphyr system for OGM to analyze the genomes of patients with a genetic disease and will discuss study results on prenatal testing, infertility and a wide variety of constitutional genetic disorders.
Seven speakers from around the world will present their experiences using the Saphyr system for OGM to analyze the genomes of patients with a genetic disease and will discuss study results on prenatal testing, infertility and a wide variety of constitutional genetic disorders.
Tuesday, January 11: Hematologic Malignancies
Leading experts studying genomic variants involved in heme malignancies will share their use of OGM and study results pertaining to Myelodysplastic syndromes, adult and pediatric B-ALL and CLL leukemias and Acute Myeloid Leukemia.
Leading experts studying genomic variants involved in heme malignancies will share their use of OGM and study results pertaining to Myelodysplastic syndromes, adult and pediatric B-ALL and CLL leukemias and Acute Myeloid Leukemia.
Wednesday, January 12: Solid Tumors
Scientists and clinicians from leading hospitals and medical research institutions in the United States and Europe will discuss their use of Saphyr to assess genomic aberrations in a wide range of solid tumors.
Scientists and clinicians from leading hospitals and medical research institutions in the United States and Europe will discuss their use of Saphyr to assess genomic aberrations in a wide range of solid tumors.
Thursday, January 13: OGM + NGS
Presentations will center on discovery and clinical research data, demonstrating that the combination of sequencing with NGS and mapping with OGM can reveal more answers in genetic diseases and cancer research.
Presentations will center on discovery and clinical research data, demonstrating that the combination of sequencing with NGS and mapping with OGM can reveal more answers in genetic diseases and cancer research.
Please register HERE.